Topical minoxidil and dietary supplement for the treatment of chemotherapy-induced alopecia in childhood: a retrospective cohort study.
Our assessment
This is a retrospective cohort study published in 2024 that examined children who experienced hair loss from chemotherapy. The researchers looked at the effects of topical minoxidil combined with a dietary supplement containing L-cystine, medicinal yeast, and pantothenic acid (called CYP). The study design means researchers looked back at patient records rather than conducting a controlled trial, and specific details on the number of participants and duration of treatment are not available in the provided data [Data not available]. Because this is a retrospective study, it can show associations but cannot prove cause and effect. Data on the exact sample size is not available in the provided text.
How it works
For children undergoing high-dose chemotherapy, hair loss is a common side effect. The study investigated whether using a topical solution applied to the scalp (minoxidil) alongside a supplement designed to support hair structure (CYP complex) could help regrow hair. This approach aims to stimulate hair follicles and provide the building blocks for new hair growth. What this means for you is that doctors are exploring combination treatments to help children recover their hair after chemotherapy, but more research is needed to confirm how effective this specific combination is [Data not available].
Safety profile
Safety data for this specific study is not available in the provided information. No side effect reports from the FDA or other adverse event data related to this combination treatment in children were provided [Data not available].
Our recommendation
Because this is a single retrospective study without full details on the number of participants or the exact results, it is too early to make a general recommendation for children undergoing chemotherapy. The findings suggest that topical minoxidil and CYP supplements may be a treatment avenue, but parents and doctors should rely on the child’s oncology team for guidance. Always consult a pediatric oncologist before starting any new treatment for chemotherapy-induced hair loss [Data not available].
AI-assisted analysis. Data sourced from PubMed.
Abstract
Chemotherapy-induced alopecia (CIA) is a common and debilitating condition in children, with limited research on its characteristics and treatment. Therefore, this study aims to describe the characteristics of pediatric patients with CIA and the treatment outcomes of topical minoxidil and L-cystine, medicinal yeast, and pantothenic acid complex-based dietary supplements (CYP). This retrospective cohort study analyzed data from patients who underwent high-dose conditioning chemotherapy followed b